Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional imaging of thymic disorders.

S Lastoria1, G Palmieri, P Muto

  • 1Department of Nuclear Medicine, National Cancer Institute, Naples, Italy.

Annals of Medicine
|November 26, 1999
PubMed
Summary

Radiopharmaceuticals like octreotide aid in diagnosing thymoma, differentiating it from benign conditions. This nuclear medicine approach improves management for myasthenia gravis patients and guides therapy selection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease.

Clinical endocrinology·2000
Same author

The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.

Clinical endocrinology·2000
Same author

FISH deletion mapping defines a single location for the Y chromosome stature gene, GCY.

Journal of medical genetics·2000
Same author

Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature.

Diseases of the colon and rectum·2000
Same author

Anergic T cells inhibit the antigen-presenting function of dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)·2000
Same author

Female pseudohermaphroditism and inefficient peak bone mass in an untreated subject affected by 21-hydroxylase congenital adrenal hyperplasia.

Journal of endocrinological investigation·2000

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • Human thymomas are rare chest tumors.
  • Computed tomography (CT) and magnetic resonance imaging (MRI) are standard diagnostic tools.
  • Distinguishing thymoma from benign thymic hyperplasia can be challenging with conventional imaging.

Purpose of the Study:

  • To evaluate the role of radiopharmaceuticals in imaging thymic disorders.
  • To assess the utility of [(111)In-DTPA-D-Phe1]-octreotide in diagnosing thymoma.
  • To explore the potential of somatostatin receptor scintigraphy in guiding thymoma treatment.

Main Methods:

  • Utilized oncotropic tracers (e.g., 201Tl-chloride, 99mTc-sestamibi, 18F-fluorodeoxyglucose) and radioligands.
  • Investigated [(111)In-DTPA-D-Phe1]-octreotide for somatostatin receptor subtype 2 binding.
  • Compared imaging findings with CT and MRI in patients with thymic conditions.

Main Results:

  • [(111)In-DTPA-D-Phe1]-octreotide concentrated in most thymoma deposits.
  • This radiotracer did not concentrate in benign lymphofollicular thymic hyperplasia.
  • Somatostatin receptor scintigraphy effectively differentiated thymoma from benign hyperplasia, unlike CT/MRI.

Conclusions:

  • [(111)In-DTPA-D-Phe1]-octreotide is valuable for diagnosing thymoma and differentiating it from benign conditions.
  • Nuclear medicine imaging, particularly somatostatin receptor scintigraphy, impacts myasthenia gravis patient management.
  • Functional imaging aids in selecting advanced thymoma patients for somatostatin analogue therapy.

Related Experiment Videos